Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Fox

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Human Vaccines & Immunotherapeutics|June 22, 2013
Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, SwitzerlandChristopher B Fox
Journal of Pharmaceutical Sciences|August 29, 2012
Characterization of TLR4 agonist effects on alhydrogel® sedimentation: a novel application of laser scattering optical profilingChristopher B Fox
Therapeutic Advances in Vaccines and Immunotherapy|July 13, 2018
It is time to accelerate building local vaccine adjuvant manufacturing capacityChristopher B Fox
Molecules (Basel, Switzerland)|September 29, 2009
Squalene emulsions for parenteral vaccine and drug deliveryChristopher B Fox
Expert Review of Vaccines|March 16, 2021
Development of thermostable vaccine adjuvantsYizhi Qi, Christopher B Fox
Journal of Chromatography. A|November 25, 2020
A Two-Step Orthogonal Chromatographic Process for Purifying the Molecular Adjuvant QS-21 with High Purity and YieldYizhi Qi, Christopher B Fox
Expert Review of Vaccines|July 27, 2013
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvantsChristopher B Fox, Jean Haensler
Expert Review of Vaccines|May 8, 2015
Are we entering a new age for human vaccine adjuvants?Derek T O'Hagan, Christopher B Fox
Pharmaceutics|July 29, 2023
Practical Considerations for Next-Generation Adjuvant Development and TranslationWilliam R Lykins, Christopher B Fox
NPJ Vaccines|July 7, 2018
AS03 stresses out macrophages: Commentary on 'Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties'Mark T Orr, Christopher B Fox
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Human Vaccines & Immunotherapeutics|June 22, 2013
Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, SwitzerlandChristopher B Fox
Journal of Pharmaceutical Sciences|August 29, 2012
Characterization of TLR4 agonist effects on alhydrogel® sedimentation: a novel application of laser scattering optical profilingChristopher B Fox
Therapeutic Advances in Vaccines and Immunotherapy|July 13, 2018
It is time to accelerate building local vaccine adjuvant manufacturing capacityChristopher B Fox
Molecules (Basel, Switzerland)|September 29, 2009
Squalene emulsions for parenteral vaccine and drug deliveryChristopher B Fox
Expert Review of Vaccines|March 16, 2021
Development of thermostable vaccine adjuvantsYizhi Qi, Christopher B Fox
Journal of Chromatography. A|November 25, 2020
A Two-Step Orthogonal Chromatographic Process for Purifying the Molecular Adjuvant QS-21 with High Purity and YieldYizhi Qi, Christopher B Fox
Expert Review of Vaccines|July 27, 2013
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvantsChristopher B Fox, Jean Haensler
Expert Review of Vaccines|May 8, 2015
Are we entering a new age for human vaccine adjuvants?Derek T O'Hagan, Christopher B Fox
Pharmaceutics|July 29, 2023
Practical Considerations for Next-Generation Adjuvant Development and TranslationWilliam R Lykins, Christopher B Fox
NPJ Vaccines|July 7, 2018
AS03 stresses out macrophages: Commentary on 'Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties'Mark T Orr, Christopher B Fox
Pageof 15